If you liked this article you might like

Why Bristol-Myers Squibb May Be a Merger Target Soon
Here's Why Johnson & Johnson Shares Are Poised for a Rally
Could Johnson & Johnson Rip Higher by 20%?
JNJ, Actelion Reportedly Move Closer to a Deal